# Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

> **NCT00382694** · PHASE2 · UNKNOWN · sponsor: **Nordic Myeloma Study Group** · enrollment: 80 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT00382694
- **Lead sponsor:** Nordic Myeloma Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382694, "Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00382694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*